Hemodynamics, fluids & transfusion
Issuing of albumin solutions to Danish public hospitals—A nationwide, retrospective, observational study based on pharmacy data from 2022
Authors' conclusion
In this nationwide study on the issuing of albumin, we observed differences across regional, hospital, and departmental settings.
Study context
- Population
- All Danish public hospitals, 2022
- Exposure
- Albumin issuing relative to total fluids across regions, hospital types and departments
- Outcome
- Issuing of IV albumin solutions (5% and 20%) relative to total issued fluids (colloid and isotonic crystalloid solutions)
- Follow-up
- 2022
Methodological detailsnationwide, pharmacy purchasing data, descriptive, Purchasing data from Danish regional hospital pharmacies used as estimate of fluid issuing
- Nationwide
- Pharmacy purchasing data
- Descriptive
- Purchasing data from Danish regional hospital pharmacies used as estimate of fluid issuing
Main finding
As reported in the abstract
Albumin share of total fluid issued
- Total fluid issued
- 1,543,199 L
- Albumin solutions issued
- 14,888 L (1%)
- Range across geographical regions
- 0.4% to 1.6%
Observational data: associations, not effects.
Further findings
Albumin share of fluid issued by department
- Intensive care units (ICUs)
- 2.9%
- Anaesthesia departments
- 2.2%
- Medical departments
- 0.8%
- Surgical departments
- 0.3%
- EDs
- 0.1%
Geographical variation in albumin share within department types
- ICUs
- 1.1% to 5.2%
- Anaesthesia departments
- 0.2% to 5.6%
Original publication
Issuing of albumin solutions to Danish public hospitals—A nationwide, retrospective, observational study based on pharmacy data from 2022. Acta Anaesthesiol Scand. Published 3 January 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →